Thomas Kündig
Vermogen: 669 000 $ op 31-07-2026
Vermogen: 669 000 $ op 31-07-2026
Thomas M Kündig is the founder of Saiba Animal Health AG (Switzerland), founded in 2013, holding the title of Chief Medical Officer since 2013.
Current jobs include Independent Director at XBiotech, Inc. starting in 2025, Director at UniversitätsSpital Zürich, and Professor at the University of Zurich.
Education history includes a doctorate from the University of Zurich.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
XBIOTECH, INC. 0,98% | 13-03-2026 | 300.000 ( 0,98% ) | 669 000 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| XBIOTECH INC. | Directeur/Bestuurslid | 24-06-2025 |
UniversitätsSpital Zürich
UniversitätsSpital Zürich Hospital/Nursing ManagementHealth Services Operates a hospital | Directeur/Bestuurslid | - |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Corporate Officer/Principal | - |
| Bedrijven | Functie | Einde |
|---|---|---|
Saiba Animal Health AG
Saiba Animal Health AG BiotechnologyHealth Technology Develops novel therapeutic medicines to address chronic diseases in pets | Oprichter | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 4 |
|---|---|
XBiotech, Inc.
XBiotech, Inc. BiotechnologyHealth Technology Engages in the discovery and development of therapeutic antibodies | Health Technology |
University of Zurich
University of Zurich Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
UniversitätsSpital Zürich
UniversitätsSpital Zürich Hospital/Nursing ManagementHealth Services Operates a hospital | Health Services |
Saiba Animal Health AG
Saiba Animal Health AG BiotechnologyHealth Technology Develops novel therapeutic medicines to address chronic diseases in pets | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau